Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.99M Buy
25,537
+30
+0.1% +$10.7K 1.57% 23
2025
Q4
$8.35M Buy
25,507
+305
+1% +$96.7K 1.46% 23
2025
Q3
$7.11M Buy
25,202
+497
+2% +$144K 1.13% 31
2025
Q2
$6.9M Buy
+24,705
New +$7M 1.08% 26

Other funds holding AMGN

Nordwand Advisors's AMGN Position: Q1 2026 in Review

Nordwand Advisors increased its Amgen (AMGN) stake by 0.12% in Q1 2026, buying an estimated $10.7K and bringing the position to 25,537 shares worth $8.99M. The position accounts for 1.57% of the portfolio, ranked #23.

Nordwand Advisors first reported a position in AMGN in Q2 2025 and has held it in 4 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Nordwand Advisors held 25,537 shares of Amgen worth $8.99M as of Q1 2026.
  • Nordwand Advisors bought 30 Amgen shares in Q1 2026, an estimated $10.7K.
  • Amgen made up 1.57% of Nordwand Advisors's portfolio in Q1 2026, its #23 holding.
  • Nordwand Advisors first reported a position in Amgen in Q2 2025 and has held it in 4 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Nordwand Advisors's 13F filing for Q1 2026, filed 7 May 2026.